ADC Therapeutics Ownership | Who Owns ADC Therapeutics?
ADC Therapeutics Ownership Summary
ADC Therapeutics is owned by 2.14% institutional investors, 14.04% insiders, and 83.82% retail investors. Redmile group is the largest institutional shareholder, holding 13.77% of ADCT shares. Biotech Growth Ord is the top mutual fund, with 1.89% of its assets in ADC Therapeutics shares.
ADCT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ADC Therapeutics | 2.14% | 14.04% | 83.82% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Redmile group | 15.67M | 13.77% | $62.67M |
| Point72 asset management | 8.14M | 7.15% | $32.54M |
| Prosight management, lp | 7.47M | 6.57% | $29.89M |
| Orbimed advisors | 5.91M | 5.19% | $23.63M |
| Blackrock | 3.55M | 4.31% | $11.23M |
| Blackrock funding, inc. /de | 4.51M | 3.97% | $18.05M |
| Morgan stanley | 3.67M | 3.23% | $14.68M |
| Nantahala capital management | 2.27M | 1.99% | $9.07M |
| Bank of america corp /de/ | 1.22M | 1.47% | $3.84M |
| Goldman sachs group | 1.59M | 1.40% | $6.38M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vantage consulting group | 683.00K | 24.36% | $2.73M |
| Prosight management, lp | 7.47M | 6.97% | $29.89M |
| Redmile group | 15.67M | 6.10% | $62.67M |
| Lynx1 capital management lp | 1.33M | 1.08% | $5.30M |
| Blue owl capital lp | 733.57K | 0.91% | $2.93M |
| Orbimed advisors | 5.91M | 0.56% | $23.63M |
| Opaleye management | 682.53K | 0.39% | $2.73M |
| Heights capital management | 326.77K | 0.36% | $1.31M |
| Nantahala capital management | 2.27M | 0.31% | $9.07M |
| Platinum investment management | 1.16M | 0.30% | $4.63M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 3.55M | 0.00% | 3.55M |
| Tcg crossover management | 1.39M | 0.27% | 1.39M |
| Lynx1 capital management lp | 1.33M | 1.08% | 1.33M |
| Artal group | 1.02M | 0.08% | 1.02M |
| Opaleye management | 682.53K | 0.39% | 682.53K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Prosight management, lp | 7.47M | 6.97% | -3.00M |
| Heights capital management | 326.77K | 0.36% | -2.51M |
| Silverarc capital management | - | - | -1.80M |
| Siren | - | - | -1.16M |
| Adage capital partners gp | - | - | -1.00M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Blackrock | 3.55M | 0.00% | 3.55M | $11.23M |
| Tcg crossover management | 1.39M | 0.27% | 1.39M | $5.56M |
| Lynx1 capital management lp | 1.33M | 1.08% | 1.33M | $5.30M |
| Artal group | 1.02M | 0.08% | 1.02M | $3.22M |
| Opaleye management | 682.53K | 0.39% | 682.53K | $2.73M |
Sold Out
| Holder | Change |
|---|---|
| Gradient investments | -11.00 |
| Federation des caisses desjardins du quebec | -20.00 |
| Northwestern mutual wealth management | -36.00 |
| Southstate | -46.00 |
| Goalvest advisory | -50.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 29 | -67.78% | 2,438,452 | -96.43% | 2 | 0.05% | 10 | -67.74% | 7 | -82.50% |
| Jun 30, 2025 | 90 | 8.43% | 68,312,257 | 26.51% | 63 | 2.51% | 31 | -20.51% | 40 | 81.82% |
| Mar 31, 2025 | 84 | -2.33% | 54,846,273 | -2.92% | 51 | 1.76% | 39 | -20.41% | 22 | 37.50% |
| Dec 31, 2024 | 86 | 8.86% | 56,494,277 | 2.93% | 53 | 1.97% | 49 | -5.77% | 16 | 45.45% |
| Sep 30, 2024 | 78 | - | 54,783,537 | 5.76% | 52 | 1.33% | 51 | -10.53% | 11 | 83.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Biotech Growth Ord | 2.13M | 1.89% | - |
| iShares Russell 2000 ETF | 1.81M | 1.61% | - |
| Fidelity Small Cap Index | 726.86K | 0.65% | -94.23K |
| iShares Russell 2000 Growth ETF | 628.23K | 0.56% | - |
| iShares Biotechnology ETF | 460.15K | 0.41% | - |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 401.24K | 0.40% | - |
| State St Russell Sm/Mid Cp® Indx SL Cl I | 401.24K | 0.36% | - |
| Vanguard Russell 2000 ETF | 344.65K | 0.31% | -24.16K |
| iShares Russell 2000 Value ETF | 286.42K | 0.29% | - |
| State St Russell Sm Cap® Indx SL Cl I | 305.70K | 0.27% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 27, 2025 | Redmile Group, LLC | - | Buy | - |
| Jun 11, 2025 | Redmile Group, LLC | - | Buy | - |
| Jun 11, 2025 | Redmile Group, LLC | - | Buy | - |
| Dec 11, 2024 | Redmile Group, LLC | - | Buy | $190.50K |
| Dec 11, 2024 | Redmile Group, LLC | - | Buy | $114.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 1 | - |
| 2025 Q2 | 2 | - |
| 2025 Q1 | - | - |
| 2024 Q4 | 4 | 1 |
| 2024 Q3 | 2 | - |
ADCT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools